Cargando…

Effect of cotrimoxazole prophylaxis on malaria occurrence in HIV-infected patients on antiretroviral therapy in sub-Saharan Africa*

OBJECTIVE: To systematically review the evidence on the effect of cotrimoxazole (CTX) on malaria in HIV-positive individuals on antiretroviral therapy (ART). METHODS: Web of Science, PubMed and MEDLINE, EMBASE, Global Health and Cochrane Library databases were searched using terms for malaria, HIV a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kasirye, R, Baisley, K, Munderi, P, Grosskurth, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2015
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671260/ https://www.ncbi.nlm.nih.gov/pubmed/25600931 http://dx.doi.org/10.1111/tmi.12463

Ejemplares similares

Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled study
por: Kasirye, Ronnie P., et al.
Publicado: (2016)

Longitudinal effect of CD4 by cotrimoxazole use on malaria incidence among HIV-infected Ugandan adults on antiretroviral therapy: a randomized controlled study
por: Kasirye, Ronnie, et al.
Publicado: (2016)

Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design
por: Anywaine, Zacchaeus, et al.
Publicado: (2015)

Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adults
por: Kasirye, Ronnie P., et al.
Publicado: (2017)

Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial
por: Anywaine, Zacchaeus, et al.
Publicado: (2018)

Cotrimoxazole prophylaxis and antiretroviral therapy: an observational cohort study in China
por: Cheng, Wei, et al.
Publicado: (2015)

Linking HIV-Infected TB Patients to Cotrimoxazole Prophylaxis and Antiretroviral Treatment in India
por: Raizada, Neeraj, et al.
Publicado: (2009)

Antiretroviral therapy uptake and coverage in four HIV community cohort studies in sub-Saharan Africa
por: Wringe, Alison, et al.
Publicado: (2012)

Effect of Stopping Cotrimoxazole Preventive Therapy on Microbial Translocation and Inflammatory Markers Among Human Immunodeficiency Virus–Infected Ugandan Adults on Antiretroviral Therapy: The COSTOP Trial Immunology Substudy
por: Kyosiimire-Lugemwa, Jacqueline, et al.
Publicado: (2020)

Factors Associated with Coverage of Cotrimoxazole Prophylaxis in HIV-Exposed Children in South Africa
por: Moodley, Dhayendre, et al.
Publicado: (2013)

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort
por: Walker, AS, et al.
Publicado: (2010)

Effects of cotrimoxazole prophylaxis on Talaromyces marneffei infection in HIV/AIDS patients receiving antiretroviral therapy: a retrospective cohort study
por: Jiang, Junjun, et al.
Publicado: (2019)

Determinants of antiretroviral therapy coverage in Sub-Saharan Africa
por: Furuoka, Fumitaka, et al.
Publicado: (2015)

Cotrimoxazole Prophylaxis and Tuberculosis Risk among People Living with HIV
por: Hoffmann, Christopher J., et al.
Publicado: (2014)

Cotrimoxazole Prophylaxis Associated With Reduced Anemia Hazard in HIV-Exposed Infants in a Malaria-Endemic Setting
por: Ewing, Alexander, et al.
Publicado: (2017)

Mortality of HIV-Infected Patients Starting Antiretroviral Therapy in Sub-Saharan Africa: Comparison with HIV-Unrelated Mortality
por: Brinkhof, Martin W. G., et al.
Publicado: (2009)

Cotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority Trial
por: Polyak, Christina S., et al.
Publicado: (2016)

Malaria Attributable to the HIV-1 Epidemic, Sub-Saharan Africa
por: Korenromp, Eline L., et al.
Publicado: (2005)

Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV
por: Ku, Stephane Wen‐Wei, et al.
Publicado: (2019)

Malaria and urbanization in sub-Saharan Africa
por: Donnelly, Martin J, et al.
Publicado: (2005)

Retention and mortality on antiretroviral therapy in sub‐Saharan Africa: collaborative analyses of HIV treatment programmes
por: Haas, Andreas D, et al.
Publicado: (2018)

Association between Antiretroviral Therapy and Cancers among Children Living with HIV in Sub-Saharan Africa
por: Haq, Heather, et al.
Publicado: (2021)

Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa
por: Harries, Anthony D, et al.
Publicado: (2010)

Increased malaria parasitaemia among adults living with HIV who have discontinued cotrimoxazole prophylaxis in Kitgum district, Uganda
por: Orishaba, Philip, et al.
Publicado: (2020)

Prospects for Malaria Eradication in Sub-Saharan Africa
por: Águas, Ricardo, et al.
Publicado: (2008)

Tackling malaria transmission in sub-Saharan Africa
por: Cohee, Lauren, et al.
Publicado: (2018)

Second-Line Antiretroviral Therapy in Sub-Saharan Africa: It Is Time to Mind the Gaps
por: Murphy, Richard A., et al.
Publicado: (2017)

Lay Social Resources for Support of Adherence to Antiretroviral Prophylaxis for HIV Prevention Among Serodiscordant Couples in sub-Saharan Africa: A Qualitative Study
por: Ware, Norma C., et al.
Publicado: (2014)

Impact of Antiretroviral Therapy on Incidence of Pregnancy among HIV-Infected Women in Sub-Saharan Africa: A Cohort Study
por: Myer, Landon, et al.
Publicado: (2010)

Systematic review of statistically-derived models of immunological response in HIV-infected adults on antiretroviral therapy in Sub-Saharan Africa
por: Sempa, Joseph B., et al.
Publicado: (2017)

Effect of cotrimoxazole prophylaxis on the incidence of malaria in HIV-infected children in 2012, in Abidjan, Côte d’Ivoire: a prospective cohort study
por: Mounkaila Harouna, Aïda, et al.
Publicado: (2015)

Interventions to improve the rate or timing of initiation of antiretroviral therapy for HIV in sub-Saharan Africa: meta-analyses of effectiveness
por: Fox, Matthew P, et al.
Publicado: (2016)

Provision of Antiretroviral Therapy for HIV-Positive TB Patients — 19 Countries, Sub-Saharan Africa, 2009–2013
por: Dokubo, E. Kainne, et al.
Publicado: (2014)

Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa: a systematic review
por: Heestermans, Tessa, et al.
Publicado: (2016)

Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts
por: Bijker, Rimke, et al.
Publicado: (2017)

ChatGPT has the potential to enhance antiretroviral therapy adherence among adolescents with HIV in sub-Saharan Africa
por: Kizito, Samuel
Publicado: (2023)

Malaria and HIV coinfection in sub-Saharan Africa: prevalence, impact, and treatment strategies
por: Kwenti, Tebit E
Publicado: (2018)

Women and HIV in Sub-Saharan Africa
por: Ramjee, Gita, et al.
Publicado: (2013)

Ten Years of Surveillance for Invasive Streptococcus pneumoniae during the Era of Antiretroviral Scale-Up and Cotrimoxazole Prophylaxis in Malawi
por: Everett, Dean B., et al.
Publicado: (2011)

Impact of HIV Drug Resistance on HIV/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub–Saharan Africa
por: Phillips, Andrew N., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lldj0l3v820f6doc709najhbau